Imigran

Sumatriptan succinate, the active ingredient in Imigran, is a Triptan presented as an injection for subcutaneous use. It treats acute migraine attacks with or without aura in adult patients.

GNH USA supplies Imigran as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imigran is a Triptan indicated for the acute management of migraine and related headache disorders. - Migraine attack: provides rapid relief of headache pain, nausea, and photophobia. - Migraine with aura: alleviates headache and associated aura symptoms. - Acute episodic migraine: reduces the need for additional rescue medication.

Common Side Effects: - Injection site pain: mild to moderate discomfort at the injection site. - Tingling or paresthesia: transient sensations in the face or extremities. - Flushing: temporary warmth or redness of the skin. - Nausea: occasional upset stomach. - Dizziness: brief light‑headedness. - Chest pressure: mild, non‑cardiac sensation.

Serious or Rare Side Effects: - Coronary vasospasm: constriction of coronary arteries that may cause chest pain. - Myocardial infarction: rare heart attack events. - Serotonin syndrome: potentially life‑threatening condition when combined with other serotonergic agents. - Severe hypertension: sudden increase in blood pressure. - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe allergic reaction: including rash, swelling, or difficulty breathing.

Before using Imigran, consider the following precautions: - Cardiovascular assessment: avoid use in patients with known coronary artery disease or uncontrolled hypertension. - Serotonergic medications: assess risk of serotonin syndrome when combined with SSRIs, SNRIs, or MAO inhibitors. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk; data are limited. - Age considerations: safety not established in pediatric patients; generally prescribed for adults. - Store at room temperature: keep in the original container, protect from moisture and light.

Imigran may interact with several drug classes. Major Interactions (Avoid): - MAO inhibitors: concurrent use may precipitate serotonin syndrome. - Ergot alkaloids: combined use can cause severe vasospasm. - Other triptans: additive vasoconstrictive effect; avoid coadministration. Moderate Interactions (Monitor Closely): - SSRIs/SNRIs: increased risk of serotonin syndrome; monitor symptoms. - Antihypertensives: may enhance blood‑pressure‑lowering effect. - CYP3A4 inhibitors: may increase sumatriptan plasma levels; adjust therapy if needed.